Literature DB >> 25082360

Improved outcome of critically ill patients with hematological malignancies: what's next?

Ayman O Soubani1, Johan Decruyenaere.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25082360     DOI： 10.1007/s00134-014-3414-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  18 in total

1.  Long-term cognitive impairment and functional disability among survivors of severe sepsis.

Authors:  Theodore J Iwashyna; E Wesley Ely; Dylan M Smith; Kenneth M Langa
Journal:  JAMA       Date:  2010-10-27       Impact factor: 56.272

2.  Perceptions of appropriateness of care among European and Israeli intensive care unit nurses and physicians.

Authors:  Ruth D Piers; Elie Azoulay; Bara Ricou; Freda Dekeyser Ganz; Johan Decruyenaere; Adeline Max; Andrej Michalsen; Paulo Azevedo Maia; Radoslaw Owczuk; Francesca Rubulotta; Pieter Depuydt; Anne-Pascale Meert; Anna K Reyners; Andrew Aquilina; Maarten Bekaert; Nele J Van den Noortgate; Wim J Schrauwen; Dominique D Benoit
Journal:  JAMA       Date:  2011-12-28       Impact factor: 56.272

3.  Survival in neutropenic patients with severe sepsis or septic shock.

Authors:  Matthieu Legrand; Adeline Max; Vincent Peigne; Eric Mariotte; Emmanuel Canet; Alexandre Debrumetz; Virginie Lemiale; Amélie Seguin; Michael Darmon; Benoît Schlemmer; Elie Azoulay
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

4.  Altered immune responses during septicaemia in patients suffering from haematological malignancies.

Authors:  K Kurz; K Garimorth; M Joannidis; D Fuchs; A Petzer; G Weiss
Journal:  Int J Immunopathol Pharmacol       Date:  2012 Jan-Mar       Impact factor: 3.219

5.  Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial.

Authors:  Elie Azoulay; Djamel Mokart; Jérôme Lambert; Virginie Lemiale; Antoine Rabbat; Achille Kouatchet; François Vincent; Didier Gruson; Fabrice Bruneel; Géraldine Epinette-Branche; Ariane Lafabrie; Rebecca Hamidfar-Roy; Christophe Cracco; Benoît Renard; Jean-Marie Tonnelier; François Blot; Sylvie Chevret; Benoît Schlemmer
Journal:  Am J Respir Crit Care Med       Date:  2010-06-25       Impact factor: 21.405

6.  Outcomes for patients with cancer admitted to the ICU requiring ventilatory support: results from a prospective multicenter study.

Authors:  Luciano C P Azevedo; Pedro Caruso; Ulysses V A Silva; André P Torelly; Eliézer Silva; Ederlon Rezende; José J Netto; Claudio Piras; Suzana M A Lobo; Marcos F Knibel; José M Teles; Ricardo A Lima; Bruno S Ferreira; Gilberto Friedman; Alvaro Rea-Neto; Felipe Dal-Pizzol; Fernando A Bozza; Jorge I F Salluh; Márcio Soares
Journal:  Chest       Date:  2014-08       Impact factor: 9.410

7.  One-year outcomes in survivors of the acute respiratory distress syndrome.

Authors:  Margaret S Herridge; Angela M Cheung; Catherine M Tansey; Andrea Matte-Martyn; Natalia Diaz-Granados; Fatma Al-Saidi; Andrew B Cooper; Cameron B Guest; C David Mazer; Sangeeta Mehta; Thomas E Stewart; Aiala Barr; Deborah Cook; Arthur S Slutsky
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

8.  Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients.

Authors:  Michael Darmon; Elie Azoulay; Corinne Alberti; Fabienne Fieux; Delphine Moreau; Jean-Roger Le Gall; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2002-10-25       Impact factor: 17.440

9.  Improved survival of critically ill cancer patients with septic shock.

Authors:  Jérôme Larché; Elie Azoulay; Fabienne Fieux; Laurent Mesnard; Delphine Moreau; Guillaume Thiery; Michaël Darmon; Jean-Roger Le Gall; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2003-09-12       Impact factor: 17.440

10.  Characteristics and outcomes of cancer patients in European ICUs.

Authors:  Fabio Silvio Taccone; Antonio A Artigas; Charles L Sprung; Rui Moreno; Yasser Sakr; Jean-Louis Vincent
Journal:  Crit Care       Date:  2009-02-06       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.